Quality concerns: when clinicians question generic manufacturing
- Dec, 12 2025
- 0
Clinicians are raising alarms over generic drug quality as manufacturing shifts overseas. A 2023 study found Indian-made generics linked to 54% more severe adverse events than U.S.-made versions - sparking debate over FDA oversight, supply chain risks, and the true cost of cheap medicine.